Literature DB >> 7016060

Hypophosphatemia in a patient with lymphoma in leukemic phase.

Y Matzner, M Prococimer, A Polliack, D Rubinger, M M Popovtzer.   

Abstract

A patient with histiocytic lymphoma had abdominal masses, hypophosphatemia, normocalcemia, and a normal serum parathyroid hormone value. After chemotherapy, transient hyperphosphatemia ensued, the abdominal masses resolved, and other manifestations of the disease were suppressed. One week after discontinuation of the chemotherapy, the abdominal masses and other signs indicative of reactivation of the malignant disease reappeared. During the relapse, the serum phosphorus level fell to 0.7 mg/dL, and urinary excretion of phosphorus became negligible. After resumption of chemotherapy, serum concentration and urinary excretion of phosphorus increased. These observation suggest that severe hypophosphatemia may be a complication of hematologic neoplasia. It is proposed that this abnormally may be caused by a shift of excessive amounts of extracellular phosphorus into the rapidly replicating malignant cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016060

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

1.  A clinical approach to common electrolyte problems: 3. Hypophosphatemia.

Authors:  C Berkelhammer; R A Bear
Journal:  Can Med Assoc J       Date:  1984-01-01       Impact factor: 8.262

2.  Life threatening hypophosphataemia in a patient with Philadelphia chromosome-positive chronic myelogenous leukaemia in acute blastic crisis.

Authors:  P Ra'anani; M Lahav; M Prokocimer; L Poles; E Theodor
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

3.  Hypophosphatemia accompanying blastic crisis in a patient with malignant lymphoma.

Authors:  J Perek; M Mittelman; U Gafter; M Djaldetti
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.